The PET scan tracks the radioactive compound or tracer as it is taken up by the cancer cells, targeting
the prostate-specific membrane antigen (PSMA).
PSMA is found on all prostate gland cells, but is elevated in cancer cells. The radioactive tracer binds
to PSMA and helps the doctor pinpoint cancer cells.